PCV46 SWITCHING PATIENTS TO ROSUVASTATIN FROM ATORVASTATIN OR OTHER STATINS IS COST-EFFECTIVE- PHARMACOECONOMIC ANALYSIS OF MERCURY I
Nov 1, 2003, 00:00
10.1016/S1098-3015(10)61690-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)61690-7/fulltext
Title :
PCV46 SWITCHING PATIENTS TO ROSUVASTATIN FROM ATORVASTATIN OR OTHER STATINS IS COST-EFFECTIVE- PHARMACOECONOMIC ANALYSIS OF MERCURY I
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61690-7&doi=10.1016/S1098-3015(10)61690-7
First page :
Section Title :
Open access? :
No
Section Order :
136